Loss of FTO leads to rapid progression into severe heart failure, shifting cardiomyocyte remodeling from hypertrophy toward atrophy and apoptosis, driven by mTORC1–S6K1 hyperactivation and impaired autophagy, while pharmacological inhibition of mTORC1–S6K1 rescues the pathology. The gene discussed is FTO; the disease is heart failure.